These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 14614364

  • 1. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
    Leibovitz E, Piglansky L, Raiz S, Greenberg D, Hamed KA, Ledeine JM, Press J, Leiberman A, Echols RM, Pierce PF, Jacobs MR, Dagan R.
    Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364
    [Abstract] [Full Text] [Related]

  • 2. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [Abstract] [Full Text] [Related]

  • 3. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
    Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, McNeeley DF, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [Abstract] [Full Text] [Related]

  • 8. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media.
    Leibovitz E, Piglansky L, Raiz S, Greenberg D, Yagupsky P, Press J, Fliss DM, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 1998 Dec; 17(12):1126-31. PubMed ID: 9877360
    [Abstract] [Full Text] [Related]

  • 9. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children.
    Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2000 Nov; 19(11):1040-5. PubMed ID: 11099083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F, Marès J, Losada I, Minguella I, Moraga F, Tarragó D, Aguilera U, Casanovas JM, Gadea G, Trías E, Cenoz S, Sistiaga A, García-Corbeira P, Pirçon JY, Marano C, Hausdorff WP.
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [Abstract] [Full Text] [Related]

  • 12. Cefprozil treatment of persistent and recurrent acute otitis media.
    Pichichero ME, McLinn S, Aronovitz G, Fiddes R, Blumer J, Nelson K, Dashefsky B.
    Pediatr Infect Dis J; 1997 May; 16(5):471-8. PubMed ID: 9154539
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R.
    Clin Infect Dis; 2005 Jul 01; 41(1):35-41. PubMed ID: 15937760
    [Abstract] [Full Text] [Related]

  • 15. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
    Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R.
    Pediatr Infect Dis J; 2012 Feb 01; 31(2):154-8. PubMed ID: 21983212
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome in children with culture-negative acute otitis media.
    Leibovitz E, Nakash E, Givon-Lavi N, Greenberg D, Satran R, Raiz S, Piglansky L, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2009 Dec 01; 28(12):1105-10. PubMed ID: 19935271
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug 01; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 19. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
    Sher L, Arguedas A, Husseman M, Pichichero M, Hamed KA, Biswas D, Pierce P, Echols R.
    Pediatr Infect Dis J; 2005 Apr 01; 24(4):301-8. PubMed ID: 15818288
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.